LUXFER HOLDINGS PLC·4

Mar 19, 9:43 AM ET

Moorefield Jeffrey C. 4

4 · LUXFER HOLDINGS PLC · Filed Mar 19, 2026

Research Summary

AI-generated summary of this filing

Updated

LUXFER (LXFR) Jeffrey C. Moorefield Exercises RSUs, Sells Shares for Taxes

What Happened

  • Jeffrey C. Moorefield (insider) exercised/converted vested restricted stock units (RSUs) on March 17–18, 2026 and had shares withheld/surrendered to satisfy tax withholding obligations. The filing shows acquisitions of 14,191 ordinary shares from vested/converted RSUs (769, 921, 6,763 and 5,738 shares). To cover taxes/exercise obligations, 5,748 shares were withheld/surrendered in several transactions (312, 373, 2,739 and 2,324 shares) for cash amounts shown totaling approximately $67,936.
  • These transactions include grants and performance-based RSU vesting (see footnotes): certain time-based RSUs vest in future tranches while performance-based RSUs granted in 2024 fully vested on March 18, 2026 after achieving EPS and TSR goals. The share withholding for taxes is a routine, non-market-sale mechanism.

Key Details

  • Transaction dates: March 17–18, 2026. Filing date: March 19, 2026 (filed within normal reporting window).
  • Prices/amounts shown for tax-withholding disposals: 312 shares at $11.80 ($3,682); 373 shares at $11.82 ($4,409); 2,739 shares at $11.82 ($32,375); 2,324 shares at $11.82 ($27,470). Total cash value of withheld shares ≈ $67,936.
  • Shares acquired via exercise/conversion (per filing): 769; 921; 6,763; 5,738 — total 14,191 shares (many were RSU grants that vested).
  • Shares owned after the transactions: not specified in the reported data.
  • Footnotes of note:
    • F1: 1-for-1 conversion subject to nominal $1.00 payment per share.
    • F2/F3: Portions represent time-based RSUs with remaining tranches vesting in future years.
    • F4–F7: Performance-based RSUs (from March 18, 2024) vested 100% on March 18, 2026 after achievement of EPS and TSR goals.
  • Transaction codes: M = exercise/conversion of derivative; F = payment of exercise price/tax liability (shares withheld); A = grant/award.

Context

  • These filings reflect RSU vesting and share withholding to satisfy tax liabilities (a routine administrative action), not an open-market sale. Withheld/surrendered shares reduce newly acquired shares delivered to the insider to cover tax obligations.
  • Performance RSUs vesting indicates corporate performance targets were met for the referenced periods; this is a compensation/vesting event rather than a directional buy/sell signal.
  • Filing appears timely (reported within two days of the transaction dates).

Insider Transaction Report

Form 4
Period: 2026-03-17
Transactions
  • Exercise/Conversion

    Ordinary Shares

    [F1]
    2026-03-17+76911,208 total
  • Tax Payment

    Ordinary Shares

    2026-03-17$11.80/sh312$3,68210,896 total
  • Exercise/Conversion

    Ordinary Shares

    [F1]
    2026-03-18+92111,817 total
  • Tax Payment

    Ordinary Shares

    2026-03-18$11.82/sh373$4,40911,444 total
  • Exercise/Conversion

    Ordinary Shares

    [F1]
    2026-03-18+6,76318,207 total
  • Tax Payment

    Ordinary Shares

    2026-03-18$11.82/sh2,739$32,37515,468 total
  • Exercise/Conversion

    Ordinary Shares

    [F1]
    2026-03-18+5,73821,206 total
  • Tax Payment

    Ordinary Shares

    2026-03-18$11.82/sh2,324$27,47018,882 total
  • Exercise/Conversion

    Restricted Stock Units

    [F1][F2]
    2026-03-177692,313 total
    Ordinary Shares (769 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    [F1][F3]
    2026-03-189211,848 total
    Ordinary Shares (921 underlying)
  • Award

    Restricted Stock Units

    [F1][F4]
    2026-03-18+6,7636,763 total
    From: 2026-03-18Ordinary Shares (6,763 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    [F1][F5]
    2026-03-186,7630 total
    From: 2026-03-18Ordinary Shares (6,763 underlying)
  • Award

    Restricted Stock Units

    [F1][F6]
    2026-03-18+5,7385,738 total
    From: 2026-03-18Ordinary Shares (5,738 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    [F1][F7]
    2026-03-185,7380 total
    From: 2026-03-18Ordinary Shares (5,738 underlying)
Footnotes (7)
  • [F1]1 for 1, subject to a nominal payment of $1.00 per Ordinary Share.
  • [F2]Represents 25% of the Restricted Stock Units granted on March 17, 2025. The remaining Restricted Stock Units will vest in three equal tranches on March 17, 2027, 2028 and 2029.
  • [F3]Represents 25% of the Restricted Stock Units granted on March 18, 2024. The remaining Restricted Stock Units will vest in two equal tranches on March 18, 2027 and 2028.
  • [F4]Represents the grant of performance-based Restricted Stock Units (at 221% target) awarded on March 18, 2024. 100% of the performance-based Restricted Stock Units were granted and vested on March 18, 2026 upon the achievement of EPS growth goals for the performance period ended December 31, 2025.
  • [F5]Represents the 100% vesting of performance-based Restricted Stock Units (at 221% target) awarded on March 18, 2024. 100% of the performance-based Restricted Stock Units were granted and vested on March 18, 2026 upon the achievement of EPS growth goals for the performance period ended December 31, 2025.
  • [F6]Represents the grant of performance-based Restricted Stock Units (at 125% target) awarded on March 18, 2024. 100% of the performance-based Restricted Stock Units were granted and vested on March 18, 2026 upon the achievement of relative total shareholder return (TSR) goals for the performance period ended December 31, 2025.
  • [F7]Represents the 100% exercise of performance-based Restricted Stock Units (at 125% target) awarded on March 18, 2024. 100% of the performance-based Restricted Stock Units were granted and vested on March 18, 2026 upon the achievement of relative total shareholder return (TSR) goals for the performance period ended December 31, 2025.
Signature
/s/ Benjamin Coulson under Power of Attorney for Jeffrey Moorefield|2026-03-19

Documents

1 file
  • 4
    wk-form4_1773927809.xmlPrimary

    FORM 4